R D Cardiff - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R D Cardiff

Showing results (121-130 of 124) with videos related to

Pageof 13

Sort By:

You have reached the last page of results.This site can display upto 124 results.

Nature Medicine|February 15, 2001

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutationsC M D'Cruz, E J Gunther, R B Boxer, et al.

Oncogene|September 30, 2014

TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferationZ Mounir, F Lin, V G Lin, et al.

Oncogene|May 10, 2016

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironmentJ Turpin, C Ling, E J Crosby, et al.

Oncogene|September 7, 2010

Control of mammary tumor differentiation by SKI-606 (bosutinib)L Hebbard, G Cecena, J Golas, et al.

Pageof 13

Search research articles

Showing results (121-130 of 124) with videos related to

Sort By:

Pageof 13

You have reached the last page of results.This site can display upto 124 results.

Nature Medicine|February 15, 2001

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutationsC M D'Cruz, E J Gunther, R B Boxer, et al.

Oncogene|September 30, 2014

TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferationZ Mounir, F Lin, V G Lin, et al.

Oncogene|May 10, 2016

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironmentJ Turpin, C Ling, E J Crosby, et al.

Oncogene|September 7, 2010

Control of mammary tumor differentiation by SKI-606 (bosutinib)L Hebbard, G Cecena, J Golas, et al.

Pageof 13